Contact Information

Theodore Lowe, Ap #867-859
Sit Rd, Azusa New York

We Are Available 24/ 7. Call Now.

Looking for the $700,000, IOM Evaluation of the California
Stem Cell Agency? Here is a Good Link

In 2012, the prestigious Institute of Medicine published a
report on California’s stem cell agency after months of studying
the research program at a cost of $700,000 to the agency itself.

Directors of the agency had
expected that the “gold standard” study would give the agency a
seal of approval
that would lead voters in California to
approve additional billions for the California Institute for
Regenerative Medicine (CIRM),
as the agency is officially
known.

The report by the IOM (now called the National Academy of
Medicine
) has a number of bad links to it on the Internet, and
some persons have reported difficulty in finding it.
Here is a link that will take you directly to the study where you
can read it free online.

Here is the beginning of an article about the study when it was
released on Dec. 6, 2012.

IOM
Recommends Sweeping Changes at California Stem Cell Agency


A blue-ribbon study of the $3 billion California stem cell
agency
 today said the program has “achieved many notable
results,†but recommended sweeping changes to remove conflict of
interest problems, clean up a troubling dual-executive arrangement
and fundamentally change the nature of the governing board.

The recommendations from the 17-month study by
the Institute of Medicine (IOM) would strip the board of its
ability to approve individual grants, greatly strengthen the role
of the agency’s president, significantly alter the role of patient
advocates on the governing board and engage the biotech industry
more vigorously.
For more on the IOM report and CIRM’s actions on its
recommendations, see the new book, “California’s
Great Stem Cell Experiment: An Inside Look at a $3 Billion Search
for Stem Cell Cures.”

In 2012, the prestigious Institute of Medicine published a
report on California’s stem cell agency after months of studying
the research program at a cost of $700,000 to the agency itself.

Directors of the agency had
expected that the “gold standard” study would give the agency a
seal of approval
that would lead voters in California to
approve additional billions for the California Institute for
Regenerative Medicine (CIRM),
as the agency is officially
known.

The report by the IOM (now called the National Academy of
Medicine
) has a number of bad links to it on the Internet, and
some persons have reported difficulty in finding it.
Here is a link that will take you directly to the study where you
can read it free online.

Here is the beginning of an article about the study when it was
released on Dec. 6, 2012.

IOM
Recommends Sweeping Changes at California Stem Cell Agency


A blue-ribbon study of the $3 billion California stem cell
agency
 today said the program has “achieved many notable
results,†but recommended sweeping changes to remove conflict of
interest problems, clean up a troubling dual-executive arrangement
and fundamentally change the nature of the governing board.

The recommendations from the 17-month study by
the Institute of Medicine (IOM) would strip the board of its
ability to approve individual grants, greatly strengthen the role
of the agency’s president, significantly alter the role of patient
advocates on the governing board and engage the biotech industry
more vigorously.
For more on the IOM report and CIRM’s actions on its
recommendations, see the new book, “California’s
Great Stem Cell Experiment: An Inside Look at a $3 Billion Search
for Stem Cell Cures.”

Share:

administrator